Vertex to Announce Third Quarter 2017 Financial Results on October 25
October 16 2017 - 4:01PM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report
its third quarter 2017 financial results on Wednesday, October 25,
2017 after the financial markets close. The company will host a
conference call and webcast at 4:30 p.m. ET. To access the call,
please dial (866) 501-1537 (U.S.) or +1 (720) 545-0001
(International).
The conference call will be webcast live and a link to the
webcast can be accessed through Vertex's website at www.vrtx.com in
the "Investors" section. To ensure a timely connection, it is
recommended that participants register at least 15 minutes prior to
the scheduled webcast. An archived webcast will be available on the
company's website.
About Vertex
Vertex is a global biotechnology company that aims to discover,
develop and commercialize innovative medicines so people with
serious diseases can lead better lives. In addition to our clinical
development programs focused on cystic fibrosis, Vertex has more
than a dozen ongoing research programs aimed at other serious and
life-threatening diseases.
Founded in 1989 in Cambridge, Mass., Vertex today has research
and development sites and commercial offices in the United States,
Europe, Canada and Australia. For seven years in a row, Science
magazine has named Vertex one of its Top Employers in the life
sciences. For additional information and the latest updates from
the company, please visit www.vrtx.com.
(VRTX-WEB)
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171016006121/en/
Vertex Pharmaceuticals
IncorporatedInvestors:Michael Partridge,
617-341-6108orEric Rojas, 617-961-7205orZach Barber,
617-341-6470
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Sep 2023 to Sep 2024